ECSIT anticorps (C-Term)
Aperçu rapide pour ECSIT anticorps (C-Term) (ABIN952019)
Antigène
Voir toutes ECSIT AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 395-425, C-Term
-
Specificité
- This antibody recognizes Human ECSIT (C-term).
-
Purification
- Affinity Chromatography on Protein A
-
Immunogène
- KLH conjugated synthetic peptide between 395-425 amino acids from the C-terminal region of human ECSIT
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- ECSIT
-
Autre désignation
- ECSIT
-
Sujet
- Adapter protein of the Toll-like and IL-1 receptor signaling pathway that is involved in the activation of NF-kappa-B via MAP3K1. Promotes proteolytic activation of MAP3K1. Involved in the BMP signaling pathway. Required for normal embryonic development (By similarity). Required for efficient assembly of mitochondrial NADH:ubiquinone oxidoreductase.Synonyms: ECSIT homolog (Drosophila), Evolutionarily conserved signaling intermediate in Toll pathway, SITPEC, Signaling intermediate in toll pathway evolutionarily conserved, mitochondrial
-
Poids moléculaire
- 49148 Da
-
ID gène
- 51295
-
NCBI Accession
- NP_001135936
-
Pathways
- Signalisation TLR, Toll-Like Receptors Cascades, SARS-CoV-2 Protein Interactome
Antigène
-